BRIEF-Allergan says FDA approves sNDA for Avycaz to include Phase III data in patients with cUTI

* FDA approves sNDA for Avycaz to include new Phase III data

in patients with complicated urinary tract infections, including

pyelonephritis

Further company coverage:

Read more